GMO U.S. Value ETF (NYSEARCA:GMOV) Short Interest Down 60.2% in July

GMO U.S. Value ETF (NYSEARCA:GMOV) was the recipient of a significant decline in short interest in July. As of July 15th, there was short interest totaling 3,493 shares, a decline of 60.2% from the June 30th total of 8,785 shares. Based on an average trading volume of 34,885 shares, the short-interest ratio is currently 0.1 days. Currently, 0.1% of the company’s shares are sold short.

GMO U.S. Value ETF Stock Up 1.2%

NYSEARCA:GMOV traded up $0.39 during midday trading on Tuesday, hitting $31.72. The stock had a trading volume of 18,322 shares, compared to its average volume of 16,917. The stock has a 50-day moving average of $30.37 and a 200 day moving average of $29.33. The company has a market capitalization of $101.50 million, a price-to-earnings ratio of 12.08 and a beta of 0.65. GMO U.S. Value ETF has a one year low of $24.79 and a one year high of $31.79.

Hedge Funds Weigh In On GMO U.S. Value ETF

A number of hedge funds and other institutional investors have recently made changes to their positions in GMOV. Legacy Capital Wealth Partners LLC raised its holdings in shares of GMO U.S. Value ETF by 6.8% in the fourth quarter. Legacy Capital Wealth Partners LLC now owns 96,504 shares of the company’s stock valued at $2,653,000 after acquiring an additional 6,156 shares in the last quarter. HighTower Advisors LLC grew its holdings in GMO U.S. Value ETF by 1.8% during the 4th quarter. HighTower Advisors LLC now owns 123,110 shares of the company’s stock worth $3,384,000 after acquiring an additional 2,182 shares in the last quarter. RPS Advisory Solutions LLC bought a new position in GMO U.S. Value ETF during the 4th quarter worth about $484,000. Aspen Investment Management Inc purchased a new position in GMO U.S. Value ETF during the 4th quarter valued at about $333,000. Finally, J.W. Cole Advisors Inc. increased its position in GMO U.S. Value ETF by 128.7% during the 4th quarter. J.W. Cole Advisors Inc. now owns 28,510 shares of the company’s stock valued at $784,000 after purchasing an additional 16,044 shares during the period.

GMO U.S. Value ETF Company Profile

The GMO US Value ETF (GMOV) is an exchange-traded fund that mostly invests in total market equity. The fund is actively managed, investing primarily in US equity securities. The fund seeks to identify undervalued US stocks using proprietary quantitative methods, capitalizing on perceived market dislocations GMOV was launched on Oct 28, 2024 and is issued by GMO.